143 related articles for article (PubMed ID: 20656026)
1. What is modulating solubility in simulated intestinal fluids?
Ottaviani G; Gosling DJ; Patissier C; Rodde S; Zhou L; Faller B
Eur J Pharm Sci; 2010 Nov; 41(3-4):452-7. PubMed ID: 20656026
[TBL] [Abstract][Full Text] [Related]
2. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
Fagerberg JH; Al-Tikriti Y; Ragnarsson G; Bergström CA
Mol Pharm; 2012 Jul; 9(7):1942-52. PubMed ID: 22651218
[TBL] [Abstract][Full Text] [Related]
3. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
Clarysse S; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Sci; 2011 Jul; 43(4):260-9. PubMed ID: 21570465
[TBL] [Abstract][Full Text] [Related]
4. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
Fuchs A; Leigh M; Kloefer B; Dressman JB
Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
[TBL] [Abstract][Full Text] [Related]
5. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
Ottaviani G; Wendelspiess S; Alvarez-Sánchez R
Mol Pharm; 2015 Apr; 12(4):1171-9. PubMed ID: 25665011
[TBL] [Abstract][Full Text] [Related]
6. Methodology for phase selection of a weak basic drug candidate, utilizing kinetic solubility profiles in bio-relevant media.
Furukawa S; Zhao C; Ohki Y
Eur J Pharm Biopharm; 2010 Feb; 74(2):298-303. PubMed ID: 19815062
[TBL] [Abstract][Full Text] [Related]
7. Dissolution behavior of various drugs in different FaSSIF versions.
Klumpp L; Leigh M; Dressman J
Eur J Pharm Sci; 2020 Jan; 142():105138. PubMed ID: 31704344
[TBL] [Abstract][Full Text] [Related]
8. Excipient-mediated supersaturation stabilization in human intestinal fluids.
Bevernage J; Forier T; Brouwers J; Tack J; Annaert P; Augustijns P
Mol Pharm; 2011 Apr; 8(2):564-70. PubMed ID: 21268663
[TBL] [Abstract][Full Text] [Related]
9. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
[TBL] [Abstract][Full Text] [Related]
10. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
[TBL] [Abstract][Full Text] [Related]
11. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
Niederquell A; Kuentz M
J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
[TBL] [Abstract][Full Text] [Related]
12. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
[TBL] [Abstract][Full Text] [Related]
13. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
14. Is bicarbonate buffer suitable as a dissolution medium?
Boni JE; Brickl RS; Dressman J
J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
[TBL] [Abstract][Full Text] [Related]
15. Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.
Takács-Novák K; Szőke V; Völgyi G; Horváth P; Ambrus R; Szabó-Révész P
J Pharm Biomed Anal; 2013 Sep; 83():279-85. PubMed ID: 23770783
[TBL] [Abstract][Full Text] [Related]
16. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects.
Vertzoni M; Fotaki N; Kostewicz E; Stippler E; Leuner C; Nicolaides E; Dressman J; Reppas C
J Pharm Pharmacol; 2004 Apr; 56(4):453-62. PubMed ID: 15099440
[TBL] [Abstract][Full Text] [Related]
17. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
18. Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid.
Ainousah BE; Perrier J; Dunn C; Khadra I; Wilson CG; Halbert G
Mol Pharm; 2017 Dec; 14(12):4170-4180. PubMed ID: 29072917
[TBL] [Abstract][Full Text] [Related]
19. Equilibrium drug solubility measurements in 96-well plates reveal similar drug solubilities in phosphate buffer pH 6.8 and human intestinal fluid.
Heikkilä T; Karjalainen M; Ojala K; Partola K; Lammert F; Augustijns P; Urtti A; Yliperttula M; Peltonen L; Hirvonen J
Int J Pharm; 2011 Feb; 405(1-2):132-6. PubMed ID: 21146596
[TBL] [Abstract][Full Text] [Related]
20. The gastrointestinal stability of lipid nanocapsules.
Roger E; Lagarce F; Benoit JP
Int J Pharm; 2009 Sep; 379(2):260-5. PubMed ID: 19524655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]